A
A Shenton
Researcher at St Mary's Hospital
Publications - 34
Citations - 3198
A Shenton is an academic researcher from St Mary's Hospital. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 25, co-authored 34 publications receiving 3003 citations.
Papers
More filters
Journal ArticleDOI
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme
Eitan Amir,D G R Evans,A Shenton,Fiona Lalloo,Anthony Moran,Caroline Boggis,Mary E. Wilson,Anthony Howell +7 more
TL;DR: The Tyrer–Cuzick model is the most consistently accurate model for prediction of breast cancer, although the accuracy of the Claus model may be improved by adjustments for other risk factors.
Journal ArticleDOI
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.
D G R Evans,Diana Eccles,Nazneen Rahman,K Young,M Bulman,Eitan Amir,A Shenton,Anthony Howell,Fiona Lalloo +8 more
TL;DR: The Manchester scoring system had the best trade-off between sensitivity and specificity at 10% prediction for the presence of mutations as shown by its highest C-statistic and was far superior to BRCAPRO.
Journal ArticleDOI
Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening
TL;DR: Women with NF1 aged <50 years have a fivefold risk of breast cancer, are in the moderate risk category and should be considered for mammography from 40 years of age, according to a population-based study.
Journal ArticleDOI
Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family
TL;DR: In high-risk families, selected in a genetics service setting, women who test positive for the familial BRCA1/BRCA2 mutation are likely to have cumulative breast cancer risks in keeping with the estimates obtained originally from large families.
Journal ArticleDOI
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
Antonis C. Antoniou,Rachel Hardy,Leslie G. Walker,D G R Evans,A Shenton,Rosalind A. Eeles,Susan Shanley,Gabriella Pichert,Louise Izatt,S. Rose,Fiona Douglas,Diana Eccles,Patrick J. Morrison,J. Scott,R.L. Zimmern,Douglas F. Easton,Pharoah Pd +16 more
TL;DR: Carrier prediction algorithms provide a rational basis for counselling individuals likely to carry BRCA1 or BRCa2 mutations and their widespread use would improve equity of access and the cost-effectiveness of genetic testing.